Status:
NOT_YET_RECRUITING
Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Chronic Total Occlusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronary arteries are in charge of oxygen supply for the myocardium. When coronary arteries develop stenosis the coronary blood flow (i.e. oxygen flow) is reduced. Chronic total occlusion (CTO) is the...
Eligibility Criteria
Inclusion
- Patients who underwent a successful coronary stent implantation for chronic coronary occlusion, eligible for long-term aspirin therapy and requiring a dual antiplatelet therapy
- Affiliated to Social Security system.
- Signature of informed consent.
- Age \> 18 years old.
Exclusion
- Dual antiplatelet therapy contra-indication
- Patient with hypersensitivity to aspirin (or any of its excipients) and/or to any of the active substance or to any of the excipients of the investigational medical product used in this study (clopidogrel);
- Patient with contraindication to aspirin and/or clopidogrel.
- No coronary stent implanted
- Age \< 18years
- Patient under guardianship
- Pregnancy or breast feeding
- Prasugrel or ticagrelor use
Key Trial Info
Start Date :
March 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
660 Patients enrolled
Trial Details
Trial ID
NCT06175377
Start Date
March 30 2024
End Date
September 30 2027
Last Update
December 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.